Sovaldi Tablet, Film Coated
Product Images NDC 61958-1501

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Sovaldi (NDC 61958-1501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sovaldi 01)

Chemical structure of sofosbuvir, the active ingredient in Sovaldi tablets. The image depicts its molecular arrangement including rings, bonds, and functional groups characteristic of the compound used in oral antiviral medication.*

FDA Label Image

Sovaldi 01a

An instructional illustration showing a hand holding a strip with a perforation marked by a scissors icon, indicating where to tear or cut the strip open.*

FDA Label Image

Sovaldi 01b

An instructional illustration showing a hand holding a sachet or packet, demonstrating how to open it by tearing along a perforated line near the top. The image includes arrows indicating the motion to open the packet and shake its contents side to side.*

FDA Label Image

Sovaldi 01c

An instructional illustration showing a person using tweezers to peel or remove a small rectangular film-coated tablet from its packaging. The image emphasizes careful handling of the tablet, likely related to Sovaldi film-coated tablets.*

FDA Label Image

Sovaldi 01d

Sovaldi 400 mg film-coated tablets blister pack by Gilead Sciences, Inc. The image shows a strip of four orange, oval tablets arranged horizontally, each imprinted with identifying codes. The packaging is designed for oral administration.*

FDA Label Image

Sovaldi 01e

An instructional illustration demonstrating how to peel open a sealed pouch or strip, showing hands lifting a tab to peel back a section of packaging, likely for accessing medication tablets inside.*

FDA Label Image

Sovaldi 01f

An instructional illustration showing hands tearing open a packet, likely demonstrating how to open a foil pouch or similar packaging. The image does not show any text or product labels.*

FDA Label Image

Sovaldi 01g

An instructional line drawing showing a hand pouring powder from a sachet into a bowl containing liquid with a spoon. The image appears to demonstrate how to mix a powdered substance, likely as part of medication preparation instructions.*

FDA Label Image

Sovaldi 01h

An instructional diagram showing a hand holding a small rectangular packet with a dotted line and scissors icon, indicating where to cut open the package.*

FDA Label Image

Sovaldi 01i

Illustration showing a hand holding a strip with a perforated section and a pair of scissors icon, indicating where to cut or separate along the perforation. The image suggests an action to open or divide the strip by pulling or tearing sideways.*

FDA Label Image

Sovaldi 01j

An illustration showing a hand holding a single film-coated tablet being placed into a container using tweezers. The image likely demonstrates proper handling or storage of the tablet, relevant for Sovaldi (sofosbuvir) film-coated tablets.*

FDA Label Image

Sovaldi 01k

FDA Label Image

Sovaldi 01l

An instructional diagram showing two hands peeling back a perforated strip from a rectangular container or package, demonstrating a step in opening or accessing the product inside.*

FDA Label Image

Sovaldi 01m

An instructional illustration showing hands opening a sealed packet or strip by tearing along the top edge, likely related to the administration or packaging of a tablet or film-coated dosage form.*

FDA Label Image

Sovaldi 01n

An instructional illustration showing a person placing a tablet into their mouth using their hand. The image highlights the oral administration of a tablet dosage form.*

FDA Label Image

Principal Display Panel (400 mg Tablet Bottle Label)

Sovaldi 400 mg (sofosbuvir) tablets label showing 28 count packaging. The label includes the drug name, strength, and a dosing instruction to take one tablet once daily. It also states the product is manufactured for Gilead Sciences, Inc., with storage and dispensing instructions.*

FDA Label Image

Principal Display Panel (400 mg Tablet Bottle Label)

Sovaldi (sofosbuvir) Tablets 400 mg film-coated tablets in a package containing 28 tablets. The label includes usage instructions, storage conditions, and manufacturing details by Gilead Sciences, Inc. It states to take 1 tablet once daily and features a pharmacist alert box regarding medications that should not be taken with Sovaldi.*

FDA Label Image

Sovaldi 04

Sovaldi 200 mg (sofosbuvir) tablets packaging label showing a 28-tablet container. The label includes dosage strength 200 mg, manufacturer Gilead Sciences, Inc., and instructions such as storage below 30°C and dispensing only in the original container. It also has a pharmacist alert about medicines that should not be taken with Sovaldi.*

FDA Label Image

Sovaldi 05

Sovaldi (sofosbuvir) oral pellets packaging label showing 150 mg per packet strength. The label includes prescription only designation, a pharmacist note about not covering the alert box, and a red alert about medicines that should not be taken with Sovaldi. The labeler is Gilead Sciences, Inc., and the package contains 28 packets.*

FDA Label Image

Sovaldi 06

Sovaldi (sofosbuvir) oral pellets 200 mg per packet label. The packaging indicates 28 packets per container and includes a pharmacist alert box warning not to cover this section with a pharmacy label and to find out about medicines that should not be taken with Sovaldi. The labeler is Gilead Sciences, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.